Clinical practice. Bacterial diarrhea.

Foodborne bacterial diarrhea is an emerging health threat that is attributable to the increased consumption of fresh vegetables and fruits, the challenges associated with producing large quantities of inexpensive foods, the increasing importation of foods from developing regions, and the growing pattern of consumption of foods in public restaurants.1 Of the more than 5.2 million cases of bacterial diarrhea that occur each year in the United States, 80% are a result of foodborne transmission.2 Personto-person spread occurs if only a small amount of a pathogen is required for infection; these pathogens include shigella, Shiga toxin–producing Escherichia coli, and protozoal and viral agents. Bacterial enteropathogens lead to an estimated 46,000 hospitalizations and 1500 deaths each year in the United States. The four most commonly reported bacterial enteropathogens in the United States — campylobacter, nontyphoid salmonella, Shiga toxin–producing E. coli, and shigella — are associated with an estimated cost of $7 billion annually.3 The first three of these organisms are spread to humans from animal reservoirs and are currently threatening our food supply.1 The highest incidence of campylobacter and salmonella infection occurs among infants, presumably because of cross-contamination in the household and the lower number of organisms required to cause clinical infection in infants than in older children and adults. Table 1 lists the projected incidence of illness caused by bacterial enteropathogens in the United States and the typical clinical manifestations of these illnesses. In addition to these organisms, other bacterial enteropathogens cause variable numbers of cases of diarrhea. Aeromonas species occur worldwide but are particularly important in tropical regions; they cause acute or persistent diarrhea or dysenteric diarrhea (passage of grossly bloody stools). Plesiomonas shigelloides is a cause of acute diarrhea associated with seafood consumption and international travel. Enterotoxigenic E. coli is a growing cause of foodborne diarrhea, and enteroaggregative E. coli is an inadequately studied but potentially important cause of endemic diarrhea in children in the United States. Although bacterial enteropathogens are of the greatest importance for children living in the developing world, this article concentrates on bacterial diarrhea in the United States, which is similar to that in other industrialized regions. A previous review provides additional information about infectious diarrhea.6 This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author’s clinical recommendations.

[1]  P. Tarr Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. , 2009, Kidney international. Supplement.

[2]  P. Cieslak,et al.  FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  P. Cieslak,et al.  Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study , 2008, Annals of the rheumatic diseases.

[4]  M. Waldor,et al.  Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. , 2000, The Journal of infectious diseases.

[5]  L B Reller,et al.  Practice guidelines for the management of infectious diarrhea. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Tobin-D'Angelo,et al.  Continued decline in the incidence of Campylobacter infections, FoodNet 1996-2006. , 2008, Foodborne pathogens and disease.

[7]  C. Walker,et al.  Rifaximin Does Not Induce Toxin Production or Phage-Mediated Lysis of Shiga Toxin-Producing Escherichia coli , 2007, Antimicrobial Agents and Chemotherapy.

[8]  H. Dupont,et al.  A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  H. Dupont,et al.  A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico. , 2009, The Journal of infectious diseases.

[10]  H. Dupont,et al.  Global etiology of travelers' diarrhea: systematic review from 1973 to the present. , 2009, The American journal of tropical medicine and hygiene.

[11]  Matthew R Moore,et al.  Surveillance for sporadic foodborne disease in the 21st century: the FoodNet perspective. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Wells,et al.  Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. , 2005, The Journal of infectious diseases.

[13]  M. Kollef,et al.  Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005 , 2008, Emerging infectious diseases.

[14]  L. Slutsker,et al.  Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of Escherichia coli O157:H7 and other enteropathogens. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  H. Dupont,et al.  Influence of Host Interleukin-10 Polymorphisms on Development of Traveler's Diarrhea Due to Heat-Labile Enterotoxin-Producing Escherichia coli in Travelers from the United States Who Are Visiting Mexico , 2008, Clinical and Vaccine Immunology.

[16]  Z. Samra,et al.  Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. , 2008, The Journal of hospital infection.

[17]  A. Lavy,et al.  Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  P. Gerner-Smidt,et al.  The significance of the number of submitted samples and patient-related factors for faecal bacterial diagnostics. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  H. Dupont,et al.  Expert review of the evidence base for prevention of travelers' diarrhea. , 2009, Journal of travel medicine.

[20]  U. Fagundes-neto,et al.  Age-specific prevalence of diffusely adherent Escherichia coli in Brazilian children with acute diarrhoea. , 2008, Journal of medical microbiology.

[21]  Hyojin Park,et al.  The Clinical Course of Postinfectious Irritable Bowel Syndrome: A Five-year Follow-up Study , 2009, Journal of clinical gastroenterology.

[22]  David W Ussery,et al.  Characterization of probiotic Escherichia coli isolates with a novel pan-genome microarray , 2007, Genome Biology.

[23]  H. Törnblom,et al.  Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  M. Tobin-D'Angelo,et al.  Preliminary FoodNet Data on the incidence of infection with pathogens transmitted commonly through food--10 States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[25]  H. Dupont,et al.  Post-Diarrhea Chronic Intestinal Symptoms and Irritable Bowel Syndrome in North American Travelers to Mexico , 2004, The American Journal of Gastroenterology.

[26]  Choong H. Park,et al.  Clinical Spectrum of Shiga Toxin–Producing Escherichia coli (STEC) in Adults and Children , 2009, Clinical pediatrics.

[27]  R. Guerrant,et al.  Acute Infectious Diarrhea , 2004 .

[28]  H. Dupont,et al.  Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. , 1987, JAMA.

[29]  D. Milewicz,et al.  Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. , 2003, The Journal of infectious diseases.

[30]  M. Larocco,et al.  A Common Polymorphism in the Interleukin 8 Gene Promoter Is Associated with Clostridium difficile Diarrhea , 2006, The American Journal of Gastroenterology.

[31]  D. Antonopoulos,et al.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. , 2008, The Journal of infectious diseases.

[32]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  H. Dupont,et al.  A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin To Prevent Travelers' Diarrhea , 2005, Annals of Internal Medicine.

[34]  F. Gejyo,et al.  Effects of Azithromycin on Shiga Toxin Production by Escherichia coli and Subsequent Host Inflammatory Response , 2002, Antimicrobial Agents and Chemotherapy.

[35]  R. Spiller Role of infection in irritable bowel syndrome , 2007, Journal of Gastroenterology.

[36]  L. McCaig,et al.  Food-related illness and death in the United States. , 1999, Emerging infectious diseases.

[37]  R. Yolken,et al.  Effect of continued oral feeding on clinical and nutritional outcomes of acute diarrhea in children. , 1988, The Journal of pediatrics.

[38]  Jane W. Marsh,et al.  High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  R. Tauxe,et al.  The use of clinical profiles in the investigation of foodborne outbreaks in restaurants: United States, 1982–1997 , 2007, Epidemiology and Infection.

[40]  Herbert L DuPont,et al.  The growing threat of foodborne bacterial enteropathogens of animal origin. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  C. Kelly,et al.  Clostridium difficile--more difficult than ever. , 2008, The New England journal of medicine.

[42]  H. Dupont,et al.  Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study. , 2008, Journal of travel medicine.

[43]  S. Groshong,et al.  A rare presentation of ischemic pseudomembranous colitis due to Escherichia coli O157:H7. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  A. Blanch,et al.  Genotypic and Phenotypic Diversity among Induced, stx2-Carrying Bacteriophages from Environmental Escherichia coli Strains , 2008, Applied and Environmental Microbiology.

[45]  C. Hedberg,et al.  Food-related illness and death in the United States. , 1999, Emerging infectious diseases.

[46]  Sandra Romero-Steiner,et al.  The Second International Conference on Women and Infectious Diseases , 2006 .

[47]  R. Spiller,et al.  Prognosis in post-infective irritable bowel syndrome: a six year follow up study , 2002, Gut.

[48]  H. Dupont,et al.  Expert review of the evidence base for self-therapy of travelers' diarrhea. , 2009, Journal of travel medicine.

[49]  I. Petersen,et al.  Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study. , 2006, The Journal of infectious diseases.